Roopa Industries Ltd.
Snapshot View

View in App

Prices View details >>

52.60 -2.20 ▼-4.0%

27 January 2023, 04:01:00 PM
Volume: 1,133

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.investorsatril.com
Market Cap 41.37 Cr.
Enterprise Value(EV) 55.86 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 1.81 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 29.07 Trailing Twelve Months Ending 2022-09
Industry PE 33.61 Trailing Twelve Months Ending 2022-09
Book Value / Share 17.06 Trailing Twelve Months Ending 2022-09
Price to Book Value 3.08 Calculated using Price: 52.60
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.79 Cr. 7,865,520 Shares
FaceValue 10
Company Profile
Roopa Industries is a part of the TGV Group, a reputed conglomerate in India, which manufactures and exports Chloro Alkali Products, Castor Oil Derivatives, Fatty Acids and Water Treatment Chemicals to various countries. The company is a manufacturer of Neutraceuticals, Fine chemicals, Drug Intermediates and Bulk Drugs since 1998.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-4.01%
1 Week
-4.97%
1 Month
-3.40%
3 Month
-19.20%
6 Month
+59.39%
1 Year
+98.49%
2 Year
+400.95%
5 Year
+261.26%
10 Year
+533.73%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) -21.14 1.88 1.96 2.07 5.63 5.97 3.51 6.41 8.41
Return on Capital Employed (%) -4.35 9.25 10.06 10.27 6.44 8.63 8.67 8.06 10.88
Return on Assets (%) -8.50 0.65 0.68 0.70 1.68 1.68 1.00 1.69 2.13

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 8 9 9 9 10 10 11 12 13 13
Non Curr. Liab. 4 4 6 8 11 10 9 9 5 5
Curr. Liab. 12 13 10 11 15 16 19 26 31 40
Minority Int.
Equity & Liab. 24 26 25 29 35 36 38 46 49 58
Non Curr. Assets 10 10 8 7 9 11 11 11 11 11
Curr. Assets 13 16 17 21 26 25 27 36 38 47
Misc. Exp. not W/O
Total Assets 24 26 25 29 35 36 38 46 49 58

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 29 31 31 30 19 30 28 29 51 73
Other Income 0 0 3 0 5 0 1 0 0 3
Total Income 29 31 34 30 24 30 29 29 51 76
Total Expenditure -29 -29 -31 -28 -22 -28 -26 -26 -48 -71
PBIDT 0 2 2 2 2 3 3 3 4 5
Interest -1 -1 -1 -2 -1 -1 -1 -1 -1 -2
Depreciation -1 -1 -1 -1 -1 -1 -1 -1 -1 -1
Taxation 0 0 0 0 0 0 0 0 0 -1
Exceptional Items 0
PAT -2 0 0 0 1 1 0 1 1 1
Adjusted EPS -3 0 0 0 1 1 0 1 1 2

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. -1 1 1 1 -1 -5 4 2 -1 2
Cash Fr. Inv. -1 0 0 0 0 3 -2 1 1 4
Cash Fr. Finan. 1 0 0 -1 2 2 -2 -3 -1 -5
Net Change -1 0 0 0 0 0 0 0 0 1
Cash & Cash Eqvt 1 0 0 0 0 0 0 0 1 1

Shareholding Pattern View Details >>

9 Qtrs 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%)
Promoter 48.03 48.03 48.03 48.03 48.03 48.03 48.03 48.03 48.03
Public 51.97 51.97 51.97 51.97 51.97 51.97 51.97 51.97 51.97
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Thu, 19 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the Quarter ended on 31 December 2022
Thu, 29 Dec 2022
Closure of Trading Window
The Trading window for Directors /officers/Designated Employees /Promoters/ immediate relatives of Designated Persons covered under "Company code of conduct for prevention of lnsider Trading will commence from 1st January 2022 till end of 48 hours after the declaration of Unaudited Financial Results of the Company for the 3rd Quarter ended 31st December 2022.
Mon, 28 Nov 2022
Disclosure Of Related Party Transactions For Half Year Ended 30 September 2022
Disclosure of related party transactions for half year ended 30 September 2022

Technical Scans View Details >>

Wed, 25 Jan 2023
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
High Decrease in 3 Months High Decrease in 3 Months
High Increase in 6 Months High Increase in 6 Months
High Increase in 1 Year High Increase in 1 Year
High Increase in 2 Years High Increase in 2 Years

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 249,518.84 1,040.75 +0.1%
Divi's Laboratories Ltd. 88,552.35 3,385.55 +1.5%
Cipla Ltd. 83,862.25 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. 69,879.98 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. 60,777.77 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. 52,497.96 1,537.85 -1.3%
Abbott India Ltd. 45,101.64 21,279.00 0.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.79 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 29.71 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-09 32.68 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 22.47 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.39 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 65.87 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 51.15 21,279.00 0.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.70 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 7.33 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-09 3.83 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.36 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.15 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 8.62 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 16.62 21,279.00 0.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 0.04 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 0.00 21,279.00 0.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 4,919.27 21,279.00 0.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 798.70 21,279.00 0.0%

FAQ's On Roopa Industries Ltd.

What is Roopa Industries share price?
Can I buy Roopa Industries shares now?
What is the Market Cap of Roopa Industries?
What are the key metrics to analyse Roopa Industries?
What is the 52 Week High and Low of Roopa Industries?
What is the trend of Roopa Industries share price?